Dr. Ye is a clinical investigator and translational researcher with expertise in multiple myeloma (MM) and CLL/SLL. She conducts clinical trials to bring innovative agents and therapeutic breakthroughs to patient care. She develops and leads multi-institutional investigator-initiated trials and serves as site principal investigator in national clinical trials with the National Cancer Institute (NCI) and Multiple Myeloma Research Foundation. Dr. Ye also collaborates with other experts to apply biomarkers such as minimal residual disease (MRD), immune profiling, and genomic alterations, in translational research and clinical applications. Dr. Ye serves on the Southwestern Oncology Group (SWOG) Multiple Myeloma Committee and the American Society for Hematology (ASH) Research Collaborative Multiple Myeloma Subcommittee.